How did RenovoRx's expenses impact its Q4 2024 revenue?
5/9/2025 04:31am
RenovoRx's Q4 2024 financial results show a total revenue of $43,000, accompanied by total expenses amounting to $2.88 million, resulting in a negative net income for the period.
|code|Ticker|Name|Date|Total Revenue|Total Expenses|Net Income|market_code|
|---|---|---|---|---|---|---|---|
|RNXT|RNXT.O|RenovoRx|2024 Q1|||-1076000|186|
|RNXT|RNXT.O|RenovoRx|2024 Q2|||-2389000|186|
|RNXT|RNXT.O|RenovoRx|2024 Q3|||-2471000|186|
|RNXT|RNXT.O|RenovoRx|2024 Q4|43000||-2878000|186|